Fischer Medical Ventures Announces FY 2026 Results and Recommends Dividend
Fischer Medical Ventures Limited today announced the outcome of its Board meeting held on May 29, 2026, confirming the audited financial results for the Quarter and Financial Year ended March 31, 2026. The company also recommended a final dividend and approved the appointment of its Internal Auditors for the upcoming financial year.The company, formerly known as Fischer Chemic Limited, reported significant financial figures across its standalone and consolidated statements for the year ended March 31, 2026.
Financial Performance Highlights
The financial results provide comprehensive details regarding the company's performance across the year and quarter.Consolidated Statement of Profit and Loss (Amounts in Lakhs)
The consolidated figures show the following performance metrics:
| Particulars | Quarter Ended March 31, 2026 | Year Ended March 31, 2026 |
|---|---|---|
| Revenue From Operations | 9,773.04 | 30,857.56 |
| Other Income | 127.78 | 1,231.37 |
| Total Income | 9,900.83 | 32,088.93 |
| Total Expenses | 10,126.13 | 27,430.55 |
| Profit (Loss) Before Exceptional and Tax | (225.30) | 4,658.38 |
| Profit (Loss) for the Period | (710.86) | 3,096.51 |
For the period, the company reported a Total Comprehensive Income of 3,118.70 Lakhs, indicating a positive financial stance for the Group.
Consolidated Balance Sheet (Amounts in Lakhs)
As of March 31, 2026, the Group reported total assets of 67,200.42 Lakhs, compared to 45,737.03 Lakhs in the previous year.
The total assets are primarily comprised of:
- Total Non-Current Assets: 25,826.29 Lakhs (up from 9,208.39 Lakhs).
- Total Current Assets: 41,374.13 Lakhs.
- Total Assets: 67,200.42 Lakhs.
In the equity and liabilities section, Total Equity stood at 38,658.53 Lakhs, reflecting a growth from 33,784.77 Lakhs in the previous fiscal year.
Operational Updates and Recommendations
Dividend RecommendationThe Board of Directors recommended a final dividend of Rs. 0.05 per equity share for the financial year ended March 31, 2026. This dividend is subject to approval by the members at the ensuing Annual General Meeting (AGM) and will be disbursed within 30 days of the AGM date.
Internal Auditor Appointment
The Board of Directors also approved the appointment of S. Ramanand Aiyer & Co., Chartered Accountants, to serve as the Internal Auditors for the financial year 2026-27. This appointment was made following the recommendation of the Audit Committee.
The financial statements for the year ended March 31, 2026, include the audited results for the Quarter and the full Financial Year, alongside the Statement of Assets & Liabilities and Statement of Cash Flow.
FISCHER Stock Price Movement
On Friday, shares of Fischer Medical Ventures Limited edged higher, closing at ₹38.14, an increase of 1.71% for the session. The stock saw strong conviction, trading a total volume of 1.02 million shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.